In a report published yesterday, Wedbush analyst David Nierengarten assigned an Outperform rating on NPS Pharmaceuticals Inc. (NASDAQ:NPSP) ahead of the release of the …
In a research report released today, Janney Capital analyst Kimberly Lee reiterated a Buy rating on NPS Pharmaceuticals (NPSP) with a $37 fair value, ahead of the company’s upcoming …
In a research report released yesterday, Janney Capital analyst Kimberly Lee reiterated a Buy rating on NPS Pharmaceuticals (NPSP) with a $37 fair …
In a research note published today, Wedbush analyst David Nierengarten reiterated an Outperform rating on NPS Pharmaceuticals (NPSP) with a $44 price target, ahead of NPSP’s upcoming second quarter …
In a research note released this morning, Janney Capital analyst Kimberly Lee maintained a Buy rating on NPS Pharmaceuticals, Inc (NPSP) with a …
